DRL says cap on trade margins a positive, posts 36% dip in Q2 PAT
Economic Times
In the second quarter of FY2027, Dr. Reddy's Labs experienced a downturn in both revenue and profit. However, the company supports new trade margin regulations that aim to improve access to vital medicines. With a commitment to boosting its core business…
Summary from Economic Times
Read the full story on Economic TimesFollow










